Auristone Secures US$4M In Seed Funding To Propel The Future Of Precision Medicine Through Epigenomics
Auristone has successfully secured USD$4 million in funding to accelerate the development and launch of our service offerings. This investment will play a crucial role in advancing our data capabilities and driving innovation in our clinical and research services.